977 related articles for article (PubMed ID: 32436996)
1. The value of clinical parameters in predicting the severity of COVID-19.
Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
[TBL] [Abstract][Full Text] [Related]
2. Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.
Li Y; Li H; Song C; Lu R; Zhao Y; Lin F; Han D; Chen L; Pan P; Dai M
Dis Markers; 2021; 2021():6304189. PubMed ID: 34900028
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
4. Differences of inflammatory and non-inflammatory indicators in Coronavirus disease-19 (COVID-19) with different severity.
Wang M; Zhu Q; Fu J; Liu L; Xiao M; Du Y
Infect Genet Evol; 2020 Nov; 85():104511. PubMed ID: 32858231
[TBL] [Abstract][Full Text] [Related]
5. Utility of the neutrophil-to-lymphocyte ratio and C-reactive protein level for coronavirus disease 2019 (COVID-19).
Yufei Y; Mingli L; Xuejiao L; Xuemei D; Yiming J; Qin Q; Hui S; Jie G
Scand J Clin Lab Invest; 2020 Nov; 80(7):536-540. PubMed ID: 32804580
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of cancer patients with COVID-19.
Yang F; Shi S; Zhu J; Shi J; Dai K; Chen X
J Med Virol; 2020 Oct; 92(10):2067-2073. PubMed ID: 32369209
[TBL] [Abstract][Full Text] [Related]
7. CXCL10 levels at hospital admission predict COVID-19 outcome: hierarchical assessment of 53 putative inflammatory biomarkers in an observational study.
Lorè NI; De Lorenzo R; Rancoita PMV; Cugnata F; Agresti A; Benedetti F; Bianchi ME; Bonini C; Capobianco A; Conte C; Corti A; Furlan R; Mantegani P; Maugeri N; Sciorati C; Saliu F; Silvestri L; Tresoldi C; ; Ciceri F; Rovere-Querini P; Di Serio C; Cirillo DM; Manfredi AA
Mol Med; 2021 Oct; 27(1):129. PubMed ID: 34663207
[TBL] [Abstract][Full Text] [Related]
8. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
[TBL] [Abstract][Full Text] [Related]
9. Retrospective Study of Clinical Features of COVID-19 in Inpatients and Their Association with Disease Severity.
Wang H; Xing Y; Yao X; Li Y; Huang J; Tang J; Zhu S; Zhang Y; Xiao J
Med Sci Monit; 2020 Dec; 26():e927674. PubMed ID: 33342993
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio, lactate dehydrogenase, D-dimer, and computed tomography score in patients with coronavirus disease 2019.
Cai YQ; Zhang XB; Zeng HQ; Wei XJ; Hu L; Zhang ZY; Ming Q; Peng QP; Chen LD
Aging (Albany NY); 2021 Sep; 13(17):20896-20905. PubMed ID: 34495869
[TBL] [Abstract][Full Text] [Related]
11. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China.
Sun L; Shen L; Fan J; Gu F; Hu M; An Y; Zhou Q; Fan H; Bi J
J Med Virol; 2020 Oct; 92(10):2055-2066. PubMed ID: 32369208
[TBL] [Abstract][Full Text] [Related]
13. Utility of inflammatory biomarkers in patients with COVID-19 infections: Bahrain experience.
Farid E; Sridharan K; Alsegai OA; Khawaja SA; Mansoor EJ; Teraifi NA; Qahtani MA; Salman JA
Biomark Med; 2021 Jun; 15(8):541-549. PubMed ID: 33988463
[No Abstract] [Full Text] [Related]
14. Clinical characteristics of COVID-19 patients in three consecutive generations of spread in Zhejiang, China.
Yao Y; Chen W; Wu X; Shen L; Shen L; Fu Y; Yang Q; Yao M; Zhou J; Zhou H
Clin Microbiol Infect; 2020 Oct; 26(10):1380-1385. PubMed ID: 32593742
[TBL] [Abstract][Full Text] [Related]
15. Analysis of factors for disease progression in 61 patients with COVID-19 in Xiaogan, Hubei, China.
Xing Y; Wang H; Yao XH; Li Y; Huang JT; Tang J; Zhu S; Liu YQ; Xiao J
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12490-12499. PubMed ID: 33336768
[TBL] [Abstract][Full Text] [Related]
16. Relationship between changes in the course of COVID-19 and ratio of neutrophils-to-lymphocytes and related parameters in patients with severe
Wang K; Wang X; Du J; Liu C; Jiang Y; Zhang H; Jiang H; Fu Q
Epidemiol Infect; 2021 Mar; 149():e81. PubMed ID: 33775266
[TBL] [Abstract][Full Text] [Related]
17. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.
Fu J; Kong J; Wang W; Wu M; Yao L; Wang Z; Jin J; Wu D; Yu X
Thromb Res; 2020 Aug; 192():3-8. PubMed ID: 32407937
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
[TBL] [Abstract][Full Text] [Related]
19. The value of C-reactive protein/albumin, fibrinogen/albumin, and neutrophil/lymphocyte ratios in predicting the severity of CoVID-19.
Torun A; Çakırca TD; Çakırca G; Portakal RD
Rev Assoc Med Bras (1992); 2021 Mar; 67(3):431-436. PubMed ID: 34468610
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19.
Gao Y; Li T; Han M; Li X; Wu D; Xu Y; Zhu Y; Liu Y; Wang X; Wang L
J Med Virol; 2020 Jul; 92(7):791-796. PubMed ID: 32181911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
